[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Capecitabine Market Status and Outlook 2018-2025

July 2018 | 163 pages | ID: GD424FB4DC8EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Teva
  • Roche
  • Mylan
  • Hikma
  • Hengrui Medicine
  • Cipla
  • Reliance Group
  • Hetero
Market by Type
  • 500 mg
  • 150 mg
Market by Application
  • Breast Cancer
  • Colorectal cancer
  • Stomach Cancer
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Capecitabine Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 500 mg
  3.1.2 150 mg
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Breast Cancer
  4.1.2 Colorectal cancer
  4.1.3 Stomach Cancer
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 500 mg Production by Region
    6.1.1.2 150 mg Production by Region
  6.1.2 Production by Application
    6.1.2.1 Breast Cancer Production by Region
    6.1.2.2 Colorectal cancer Production by Region
    6.1.2.3 Stomach Cancer Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 500 mg Demand by Region
    6.2.1.2 150 mg Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Breast Cancer Demand by Region
    6.2.2.2 Colorectal cancer Demand by Region
    6.2.2.3 Stomach Cancer Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Teva
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Roche
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Mylan
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Hikma
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Hengrui Medicine
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Cipla
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Reliance Group
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Hetero
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Capecitabine Industry Dynamics & Regulations List
Table Global Capecitabine Sales Revenue, Cost and Margin, 2015-2018E
Table Global Capecitabine Market Status by Type 2015-2018E, in USD Million
Table Global Capecitabine Market Status by Application 2015-2018E, in USD Million
Table Global Capecitabine Market Status by Application 2015-2018E, in Volume
Table Global Capecitabine Market by Region 2015-2018E, in USD Million
Table Global Capecitabine Market Share by Region in 2018, in USD Million
Table Global Capecitabine Market by Region 2015-2018E, in Volume
Table Global Capecitabine Market Share by Region in 2018, in Volume
Table 500 mg Production Value by Region 2015-2018E, in USD Million
Table 500 mg Production Volume by Region 2015-2018E, in Volume
Table 150 mg Production Value by Region 2015-2018E, in USD Million
Table 150 mg Production Volume by Region 2015-2018E, in Volume
Table Breast Cancer Production Value by Region 2015-2018E, in USD Million
Table Breast Cancer Production Volume by Region 2015-2018E, in Volume
Table Colorectal cancer Production Value by Region 2015-2018E, in USD Million
Table Colorectal cancer Production Volume by Region 2015-2018E, in Volume
Table Stomach Cancer Production Value by Region 2015-2018E, in USD Million
Table Stomach Cancer Production Volume by Region 2015-2018E, in Volume
Table 500 mg Market Size by Region 2015-2018E, in USD Million
Table 500 mg Market Size by Region 2015-2018E, in Volume
Table 150 mg Market Size by Region 2015-2018E, in USD Million
Table 150 mg Market Size by Region 2015-2018E, in Volume
Table Breast Cancer Market Size by Region 2015-2018E, in USD Million
Table Breast Cancer Market Size by Region 2015-2018E, in Volume
Table Colorectal cancer Market Size by Region 2015-2018E, in USD Million
Table Colorectal cancer Market Size by Region 2015-2018E, in Volume
Table Stomach Cancer Market Size by Region 2015-2018E, in USD Million
Table Stomach Cancer Market Size by Region 2015-2018E, in Volume
Table GlobalCapecitabine Forecast by Type 2019F-2025F, in USD Million
Table Capecitabine Forecast by Type 2019F-2025F, in Volume
Table Capecitabine Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Capecitabine Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Capecitabine Market Forecast by Region 2019F-2025F, in USD Million
Table Capecitabine Market Forecast by Region 2019F-2025F, in Volume
Table Teva Information
Table Capecitabine Sales, Cost, Margin of Teva
Table Roche Information
Table Capecitabine Sales, Cost, Margin of Roche
Table Mylan Information
Table Capecitabine Sales, Cost, Margin of Mylan
Table Hikma Information
Table Capecitabine Sales, Cost, Margin of Hikma
Table Hengrui Medicine Information
Table Capecitabine Sales, Cost, Margin of Hengrui Medicine
Table Cipla Information
Table Capecitabine Sales, Cost, Margin of Cipla
Table Reliance Group Information
Table Capecitabine Sales, Cost, Margin of Reliance Group
Table Hetero Information
Table Capecitabine Sales, Cost, Margin of Hetero
Table Global Capecitabine Sales Revenue by Company 2015-2017, in USD Million
Table Global Capecitabine Sales Volume by Company 2015-2017, in Volume
Table Global Capecitabine Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Capecitabine Picture
Figure Capecitabine Industry Chain Diagram
Figure Global Capecitabine Sales Revenue 2015-2018E, in USD Million
Figure Global Capecitabine Sales Volume 2015-2018E, in Volume
Figure Global Capecitabine Market Status by Type 2015-2018E, in Volume
Figure North America Capecitabine Market Size and Growth 2015-2018E, in USD Million
Figure North America Capecitabine Market Size and Growth 2015-2018E, in Volume
Figure Europe Capecitabine Market Size and Growth 2015-2018E, in USD Million
Figure Europe Capecitabine Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Capecitabine Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Capecitabine Market Size and Growth 2015-2018E, in Volume
Figure South America Capecitabine Market Size and Growth 2015-2018E, in USD Million
Figure South America Capecitabine Market Size and Growth 2015-2018E, in Volume
Figure Middle East Capecitabine Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Capecitabine Market Size and Growth 2015-2018E, in Volume
Figure Africa Capecitabine Market Size and Growth 2015-2018E, in USD Million
Figure Africa Capecitabine Market Size and Growth 2015-2018E, in Volume
Figure Global Capecitabine Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Capecitabine Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Capecitabine Sales Price Forecast 2019F-2025F
Figure Global Capecitabine Gross Margin Forecast 2019F-2025F
Figure Global Capecitabine Sales Revenue by Company in 2018, in USD Million
Figure Global Capecitabine Price by Company in 2018
Figure Global Capecitabine Gross Margin by Company in 2018


More Publications